Author: GO2 for Lung Cancer Treatment and Trials Navigator, Renee Botello MSc Tagrisso (osimertinib) has been the treatment of choice and effective standard of care option for the treatment of EGFR+ non-small cell lung cancer (NSCLC) since its FDA [...]
Author: Rashmi Acharya, MS, Science and Research Specialist, GO2 for Lung Cancer The 2021 World Conference on Lung Cancer (WCLC) had multiple researchers presenting their findings on broad areas of research in early-stage lung cancer. These presentations bring highly [...]
Dear Lung Cancer Community, As we dive into 2019 and further our efforts to advance new life-saving research and treatments for the lung cancer community, we want to take a moment to say thank you and reflect on what [...]
A lung cancer diagnosis can be overwhelmingly emotional and complicated. To provide support during this confusing period, Lung Cancer Alliance started a national HelpLine dedicated exclusively to lung cancer. Caring, trained support professionals answer calls to help patients, caregivers [...]
